NMPA Approval

Insulin Glargine Injection

Approval Number

国药准字SJ20140004

Registration Date

July 24, 2023

Previous Approval Numbers

S20140004

Drug Information

Generic Name

甘精胰岛素注射液

Trade Name

来得时

Dosage Form

注射剂

Strength

3ml:300单位/笔芯/预填充(solostar)

Drug Type

生物制品

Registration Date

July 24, 2023

Expiry Date

July 23, 2028

Company Address

D-65926 Frankfurt am Main, Germany

Company Address

Industriepark Hoechst,Brueningstrasse 50,D-65926 Frankfurt am Main, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

甘精胰岛素注射液 - NMPA 批准文号 | MedPath